showed a trendp=0.0851
RT+CpG+OX40 significantly increased the non-Treg CD4+:Treg ratio compared to treatment with RT alone and showed a trend (p=0.0851) toward an increased ratio when compared to PBS treated tumors.
RT+CpG+OX40 significantly increased the non-Treg CD4+:Treg ratio compared to treatment with RT alone and showed a trend (p=0.0851) toward an increased ratio when compared to PBS treated tumors.